The NeuroBlate System combines magnetic resonance imaging (MRI) and software-based visualization to allow surgeons to remotely ablate tumors in many locations in the brain, at the surface or deep inside, through a computer module. An MRI compatible robotic probe driver helps the surgeon precisely guide the laser probe to the tumor and apply heat to it in controlled amounts, until the targeted tissue is destroyed.
"It is exciting to see the rapid adoption of NeuroBlate by the neurosurgical community, not just in cases of recurrent tumors, but as a first-line treatment for a broad spectrum of tumors," said Gene Barnett, M.D., director, Burkhardt Brain Tumor and Neuro-Oncology Center and director, Cleveland Clinic Gamma Knife Center, Cleveland Clinic, Cleveland, Ohio.
The NeuroBlate System is considered to be minimally invasive surgery. With the NeuroBlate System, a surgeon makes a small hole in the skull, approximately as wide as a pencil. A small probe is then used to deliver laser light energy to heat and destroy the tumor.
"For some tumors that are difficult to access with standard surgery, or considered 'inoperable,' NeuroBlate is providing a solution that can significantly impact patient prognosis," said Eric C. Leuthardt, M.D., associate professor of neurological surgery, Center for Innovation in Neuroscience and Technology, Washington University School of Medicine, St. Louis, Mo.
to read the rest of the story, please go to: http://www.prnewswire.com/news-releases/monteris-medical-reaches-milestone-for-neuroblate-system-274654211.html